To evaluate the safety and effectiveness of the AXIOS™ Stent with Electrocautery Enhanced Delivery System in the management of symptoms of acute cholecystitis as an alternative to percutaneous gallbladder drainage.
This study is a prospective, single arm, multi center trial. Treatment of up to 30 patients will take place at up to 9 clinical centers. Patients who meet all eligibility criteria will receive the AXIOS stent for up to 60 days indwell and 72 hour follow-up after stent removal.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
30
Patients who are at high risk or unsuitable for surgery will receive an AXIOS stent under EUS guidance for treatment of acute cholecystitis.
University of Colorado Denver
Aurora, Colorado, United States
Emory University School of Medicine
Atlanta, Georgia, United States
Parkview Medical Center
Fort Wayne, Indiana, United States
Mayo Clinic
Rochester, Minnesota, United States
Number of Days to Resolution of Acute Cholecystitis
Time to resolution of acute cholecystitis measured in days. Resolution is defined as either a fever of less than 100.5°F, or at least a 4-point decrease in the pain score, or WBC count less than 12,000/cc, with improvement in at least two of these categories without the deterioration of the third category.
Time frame: Up to 15 weeks
Rate of Re-interventions
Rate of re-interventions including but not limited to stent migration, stent occlusion by GB stones, and luminal debridement.
Time frame: Through study completion, Up to 15 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Cleveland Clinic
Cleveland, Ohio, United States
Virginia Mason Medical Center
Seattle, Washington, United States
UZ Leuven
Leuven, Belgium